- 专利标题： BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS
-
申请号： US16239051申请日： 2019-01-03
-
公开(公告)号： US20190241560A1公开(公告)日： 2019-08-08
- 发明人: Liang Lu , Liangxing Wu , Ding-Quan Qian , Wenqing Yao
- 申请人： Incyte Corporation
- 主分类号： C07D471/04
- IPC分类号： C07D471/04
摘要：
The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR4 enzyme and are useful in the treatment of FGFR4-associated diseases such as cancer.
公开/授权文献
- US10738048B2 Bicyclic heterocycles as FGFR4 inhibitors 公开/授权日：2020-08-11
信息查询
